BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8293398)

  • 1. Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study.
    Castellani R; Visscher DW; Wykes S; Sarkar FH; Crissman JD
    Cancer; 1994 Jan; 73(2):344-9. PubMed ID: 8293398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
    Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The autocrine loop of epidermal growth factor receptor-epidermal growth factor / transforming growth factor-alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC549.
    Narita T; Taga T; Sugita K; Nakazawa S; Ohta S
    Jpn J Cancer Res; 2001 Mar; 92(3):269-78. PubMed ID: 11267936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.
    Gorgoulis V; Aninos D; Priftis C; Evagelopoulou C; Karameris A; Kanavaros P; Spandidos DA
    In Vivo; 1992; 6(3):291-6. PubMed ID: 1391697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.
    Gorgoulis V; Aninos D; Mikou P; Kanavaros P; Karameris A; Joardanoglou J; Rasidakis A; Veslemes M; Ozanne B; Spandidos DA
    Anticancer Res; 1992; 12(4):1183-7. PubMed ID: 1503407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues.
    Scala S; Saeki T; Lynch A; Salomon D; Merino MJ; Bates SE
    Diagn Mol Pathol; 1995 Jun; 4(2):136-42. PubMed ID: 7551294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
    Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
    Cancer; 1990 May; 65(9):1980-4. PubMed ID: 2372767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
    Filipe MI; Osborn M; Linehan J; Sanidas E; Brito MJ; Jankowski J
    Br J Cancer; 1995 Jan; 71(1):30-6. PubMed ID: 7819044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors in progression of human esophageal and gastric carcinomas.
    Yoshida K; Yasui W; Ito H; Tahara E
    Exp Pathol; 1990; 40(4):291-300. PubMed ID: 2098274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of human gastric carcinomas and expression of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor and p185c-erbB-2.
    Suzuki T; Tsuda T; Haruma K; Yoshihara M; Sumii K; Kajiyama G
    Oncology; 1995; 52(5):385-91. PubMed ID: 7637956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors.
    Yoshida K; Kyo E; Tsuda T; Tsujino T; Ito M; Niimoto M; Tahara E
    Int J Cancer; 1990 Jan; 45(1):131-5. PubMed ID: 2298497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.
    Tauchi K; Hori S; Itoh H; Osamura RY; Tokuda Y; Tajima T
    Virchows Arch A Pathol Anat Histopathol; 1989; 416(1):65-73. PubMed ID: 2573192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer.
    Sainsbury JR; Farndon JR; Needham GK; Malcolm AJ; Harris AL
    Lancet; 1987 Jun; 1(8547):1398-402. PubMed ID: 2884496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
    Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
    Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
    Morishige K; Kurachi H; Amemiya K; Adachi H; Inoue M; Miyake A; Tanizawa O; Sakoyama Y
    Cancer Res; 1991 Nov; 51(21):5951-5. PubMed ID: 1718591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters.
    Lundy J; Schuss A; Stanick D; McCormack ES; Kramer S; Sorvillo JM
    Am J Pathol; 1991 Jun; 138(6):1527-34. PubMed ID: 1711294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.
    Cohen DW; Simak R; Fair WR; Melamed J; Scher HI; Cordon-Cardo C
    J Urol; 1994 Dec; 152(6 Pt 1):2120-4. PubMed ID: 7525998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization.
    Sasano H; Suzuki T; Shizawa S; Kato K; Nagura H
    Mod Pathol; 1994 Sep; 7(7):741-6. PubMed ID: 7824507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of epidermal growth factor receptor in node-positive breast cancer.
    Grimaux M; Romain S; Remvikos Y; Martin PM; Magdelénat H
    Breast Cancer Res Treat; 1989 Oct; 14(1):77-90. PubMed ID: 2690971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of estrogen receptor and epidermal growth factor receptor content of primary and involved nodes in human breast cancer.
    Mori T; Morimoto T; Komaki K; Monden Y
    Cancer; 1991 Aug; 68(3):532-7. PubMed ID: 2065272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.